Nonsteroid anti-inflammatory drug-induced gastroduodenal injury

被引:18
作者
Lai, Larry H. [1 ]
Chan, Francis K. L. [1 ]
机构
[1] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China
关键词
aspirin; clopidogrel; cyclooxygenase-2; gastrointestinal bleeding; nonsteroid anti-inflammatory drug; peptic ulcer; proton pump inhibitor; PROTON-PUMP INHIBITORS; GASTROINTESTINAL ULCER COMPLICATIONS; LOW-DOSE ASPIRIN; NSAID USE; ANTIPLATELET AGENTS; CARDIOVASCULAR RISK; COST-EFFECTIVENESS; CONCOMITANT USE; CLINICAL-TRIAL; CLOPIDOGREL;
D O I
10.1097/MOG.0b013e328331549f
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Purpose of review This article reviews selected publications related to nonsteroid anti-inflammatory drug (NSAID)-induced gastroduodenal toxicity in recent years. Recent findings This article provides a comprehensive review of the latest evidence on the epidemiology of NSAID-induced gastroduodenal injury, recommendations on optimal gastroprotective regimens among patients in need of NSAID, risk stratification approach by considering gastrointestinal and cardiovascular risks, and negative interaction between proton pump inhibitors (PPIs) and clopidogrel. Summary Current evidence indicates that a PPI and a cyclooxygenase (COX)-2-selective NSAID provides the best gastric protection. In light of potential cardiovascular hazard of NSAIDs, physicians should select an NSAID according to individual patients' cardiovascular risk (i.e., naproxen vs. a nonnaproxen NSAID). The choice of gastroprotective therapy depends on the number and nature of gastrointestinal risk factors. PPI co-therapy is recommended in patients with high gastrointestinal risk on aspirin. Whether there is any clinically important interaction between PPIs and clopidogrel remains uncertain.
引用
收藏
页码:544 / 548
页数:5
相关论文
共 33 条
[1]
[Anonymous], 2002, Cochrane Database Syst Rev, DOI 10.1002/14651858.CD002296
[2]
ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use [J].
Bhatt, Deepak L. ;
Scheiman, James ;
Abraham, Neena S. ;
Antman, Elliott M. ;
Chan, Francis K. L. ;
Furberg, Curt D. ;
Johnson, David A. ;
Mahaffey, Kenneth W. ;
Quigley, Eamonn M. ;
Harrington, Robert A. ;
Bates, Eric R. ;
Bridges, Charles R. ;
Eisenberg, Mark J. ;
Ferrari, Victor A. ;
Hlatky, Mark A. ;
Kaul, Sanjay ;
Lindner, Jonathan R. ;
Moliterno, David J. ;
Mukherjee, Debabrata ;
Schofield, Richard S. ;
Rosenson, Robert S. ;
Stein, James H. ;
Weitz, Howard H. ;
Wesley, Deborah J. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (11) :2890-2907
[3]
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-Segment elevation myocardial infarction - Summary article - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina) [J].
Braunwald, E ;
Antman, EM ;
Beasley, JW ;
Califf, RM ;
Cheitlin, MD ;
Hochman, JS ;
Jones, RH ;
Kereiakes, D ;
Kupersmith, J ;
Levin, TN ;
Pepine, CJ ;
Schaeffer, JW ;
Smith, EE ;
Steward, DE ;
Theroux, P ;
Gibbons, RJ ;
Alpert, JS ;
Faxon, DP ;
Fuster, V ;
Gregoratos, G ;
Hiratzka, LF ;
Jacobs, AK ;
Smith, SC .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (07) :1366-1374
[4]
Brown TJ, 2006, HEALTH TECHNOL ASSES, V10, P1
[5]
Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding [J].
Chan, FKL ;
Ching, JYL ;
Hung, LCT ;
Wong, VWS ;
Leung, VKS ;
Kung, NNS ;
Hui, AJ ;
Wu, JCY ;
Leung, WK ;
Lee, VWY ;
Lee, KKC ;
Lee, YT ;
Lau, JYW ;
To, KF ;
Chan, HLY ;
Chung, SCS ;
Sung, JJY .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :238-244
[6]
Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis [J].
Chan, FKL ;
Hung, LCT ;
Suen, BY ;
Wu, JCY ;
Lee, KC ;
Leung, VKS ;
Hui, AJ ;
To, KF ;
Leung, WK ;
Wong, VWS ;
Chung, SCS ;
Sung, JJY .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (26) :2104-2110
[7]
Management of Patients on Nonsteroidal Anti-inflammatory Drugs: A Clinical Practice Recommendation From the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents [J].
Chan, Francis K. L. ;
Abraham, Neena S. ;
Scheiman, James M. ;
Laine, Loren .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (11) :2908-2918
[8]
Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial [J].
Chan, Francis Ka Leung ;
Wong, Vincent Wai Sun ;
Suen, Bing Yee ;
Wu, Justin Che Yuen ;
Ching, Jessica Yuet Ling ;
Hung, Lawrence Cheung Tsui ;
Hui, Aric Josun ;
Leung, Vincent King Sun ;
Lee, Vivian Wing Yan ;
Lai, Larry Hin ;
Wong, Grace Lai Hung ;
Chow, Dorothy Kai Lai ;
To, Ka Fa ;
Leung, Wai Keung ;
Chiu, Philip Wai Yan ;
Lee, Yuk Tong ;
Lau, James Yun Wong ;
Chan, Henry Lik Yuen ;
Ng, Enders Kwok Wai ;
Sung, Joseph Jao Yiu .
LANCET, 2007, 369 (9573) :1621-1626
[9]
Preventing non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: are older strategies more cost-effective in the general population? [J].
Elliott, RA ;
Hooper, L ;
Payne, K ;
Brown, TJ ;
Roberts, C ;
Symmons, D .
RHEUMATOLOGY, 2006, 45 (05) :606-613
[10]
Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin [J].
Gilard, Martine ;
Arnaud, Bertrand ;
Cornily, Jean-Christophe ;
Le Gal, Gregoire ;
Lacut, Karine ;
Le Calvez, Genevive ;
Mansourati, Jacques ;
Mottier, Dominique ;
Abgrall, Jean-Francois ;
Boschat, Jacques .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (03) :256-260